Content |
Owners
History
2025: Changing the procurement system for complex medical equipment - now all through Moscow
October 10, 2025 Ministry of Health Russia published a draft resolution on the centralization of purchases of expensive medical equipment through. Federal Center for Drug Supply Planning and Organization (FTPiLO)
According to Forbes, if a regulatory act is adopted, from 2026, the purchase of medical equipment (ventilators, MRI, CT, PET/CT), funded within the framework of the national projects "Long and Active Life" and "Family," will be carried out through FTPiLO.
The competence of the regions boils down to the formation and submission of applications to the Federal Target Program, which will be authorized to select suppliers.
The explanatory note to the project states that the key goals of the innovation are to reduce the administrative burden on the regions, optimize the use of budget allocations due to the scale of purchases and eliminate the price imbalance in the purchase of identical medical equipment in different regions.
Based on the comments of market participants, Forbes points out the risks of the idea of centralizing procurement:
- possible supply delays due to the difficulty of coordinating 85 regions;
- separation of technical assignments from the real needs of medical institutions;
- displacement from the market of medium and small producers;
- reduced flexibility and possibility of equipment retrofitting;
- probability of lobbying the interests of individual suppliers.
Experts from Report Service note a trend towards a decrease in the number of market participants and an increase in the share of large players. In 2025, there is an increase in the share of the Russian Electron (up to 9.9% in the CT market) and the Belarusian Adani (24.6%), while maintaining the leadership of General Electric (35.5% in the CT market).
Of particular concern is the standardization of the configuration, which may not take into account the needs of specialized medical centers. To minimize risks, it is proposed to introduce price benchmarking, split lots and create expert advice with the participation of doctors.[1]
2022: The Ministry of Health approved a single operator for the purchase of cancer drugs for federal medical centers
In September 2022, an order was signed by which the Ministry of Health approved a single operator for the purchase of cancer drugs for federal medical centers. It was the Federal Center for the Planning and Organization of Drug Provision of Citizens (FCPILO).
This institution is endowed with the right of suppliers of purchases of oncological drugs for federal medical centers. We are talking about 13 drugs: vincristine, doxorubicin, idarubicin, ipilimumab, carboplatin, nivolumab, pembrolizumab, pertuzumab, ramucirumab, temozolomide, epirubicin and etoposide.
The procedure for working in this status of the FCPILO will be as follows:
- it will process requests for cancer drugs from federal medical centers;
- generate lists of necessary purchases;
- place them in the Unified Procurement Information System (UIS);
- Identify the supplier
- federal medical centers will have to justify the operator the maximum price of the contract for the purchase of the necessary drugs.
The order of the Ministry of Health notes that the Federal State Budgetary Institution, as before, will be able to independently purchase cancer drugs from a single supplier in the manner and cases provided for by Art. 93 No. 44-FZ "On the contract system in the field of procurement of goods, works, services to meet state and municipal needs."
To the list of federal institutions for which cancer drugs will now purchase PKU, entered the First St. Petersburg State Medical University named after Academician I.P. Pavlov, National Medical Research Center of Hematology, N.N. Petrov National Medical Research Center of Oncology, N.N. Blokhin National Medical Research Center of Oncology, National Medical Research Center of Radiology, National Medical Research Center named after V.A. Almazova, National Medical and Surgical Center named after N.I. Pirogov, National Medical Research Center of Oncology in Rostov-on-Don, Russian Scientific Center for Radiology and Surgical Technologies named after Academician A.M. Granova, Russian Scientific Center of X-ray Radiology and National Medical Research Center of Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakova.[2]
Notes
| | The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |

